Changes in hemoglobin values in elite cross-country skiers from 1987 to 1999

被引:36
作者
Videman, T
Lereim, I
Hemmingson, P
Turner, MS
Rousseau-Bianchi, MP
Jenoure, P
Raas, E
Schönhuber, H
Rusko, H
Stray-Gundersen, J
机构
[1] Int Ski Federat, Med Comm, Jyvaskyla, Finland
[2] KIHU, Res Inst Olymp Sports, Jyvaskyla, Finland
关键词
cross country skiing; aerobic performance; blood doping; doping control; hemoglobin; erythropoietin; ethics in sport; polycythemia;
D O I
10.1034/j.1600-0838.2000.010002098.x
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Hemoglobin data have been available from ski teams beginning from 1987, and from 1989 to 1999 we have followed hemoglobin values in elite cross-country skiers in international competitions. The mean values at the 1989 World Nordic Ski Championships were lon er than population reference values, as would be expected from plasma volume expansion associated with endurance training. However, an increase, particularly in the maximal values, became obvious in 1994 and rose further in 1996. These extreme values provide both a health risk to the individual athlete and unfair competition. After a rule limiting hemoglobin values was introduced, the drop of the highest values was remarkable: among men 15 g/l (0.23 mmol/l) and among women 42 g/l (0.65 mmol/l). It would appear that the rule had achieved its goal of limiting extreme hemoglobin values. Yet the mean hemoglobin concentrations in men and women have continued to rise, suggesting the continued use of artificial methods to increase total hemoglobin mass.
引用
收藏
页码:98 / 102
页数:5
相关论文
共 23 条
[1]   PLASMA + RED CELL VOLUME AFTER PROLONGED SEVERE EXERCISE [J].
ASTRAND, P ;
SALTIN, B .
JOURNAL OF APPLIED PHYSIOLOGY, 1964, 19 (05) :829-+
[2]   Effects of erythropoietin administration in training athletes and possible indirect detection in doping control [J].
Audran, M ;
Gareau, R ;
Matecki, S ;
Durand, F ;
Chenard, C ;
Sicart, MT ;
Marion, B ;
Bressolle, F .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1999, 31 (05) :639-645
[3]   HIGH-ALTITUDE TRAINING - ASPECTS OF HEMATOLOGICAL ADAPTATION [J].
BERGLUND, B .
SPORTS MEDICINE, 1992, 14 (05) :289-303
[4]   Population pharmacodynamics for monitoring epoetin in athletes [J].
Bressolle, F ;
Audran, M ;
Gareau, R ;
Baynes, RD ;
Guidicelli, C ;
Gomeni, R .
CLINICAL DRUG INVESTIGATION, 1997, 14 (03) :233-242
[5]   THE EFFECTS OF RED-BLOOD-CELL INFUSION ON 10-KM RACE TIME [J].
BRIEN, AJ ;
SIMON, TL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (20) :2761-2765
[6]  
EKBLOM B, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P88
[7]   RESPONSE TO EXERCISE AFTER BLOOD LOSS AND REINFUSION [J].
EKBLOM, B ;
GOLDBARG, AN ;
GULLBRING, B .
JOURNAL OF APPLIED PHYSIOLOGY, 1972, 33 (02) :175-+
[8]  
ENDSJO TO, 1991, HOJD ANN M NORW SOC
[9]   TRANSFERRIN SOLUBLE RECEPTOR - A POSSIBLE PROBE FOR DETECTION OF ERYTHROPOIETIN ABUSE BY ATHLETES [J].
GAREAU, R ;
GAGNON, MG ;
THELLEND, C ;
CHENARD, C ;
AUDRAN, M ;
CHANAL, JL ;
AYOTTE, C ;
BRISSON, GR .
HORMONE AND METABOLIC RESEARCH, 1994, 26 (06) :311-312
[10]  
HEMMINGSSON P, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P174